ArticleVaccine2022

Self-reported reactogenicity of CoronaVac (Sinovac) compared with Comirnaty (Pfizer-BioNTech): A prospective cohort study with intensive monitoring.

Francisco Tsz Tsun Lai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.